Neuropsychiatric Disease and Treatment

REVIEWERS FOR VOLUME 1, 2005

Neuropsychiatric Disease and Treatment 2006, 2:117-117

Published Date: 15 March 2006

Differentiating cognitive impairment from symptoms of anxiety in postcoronary artery bypass grafting encephalopathy: a case report

Frank M Dattilio, John E Castaldo

Neuropsychiatric Disease and Treatment 2006, 2:111-116

Published Date: 15 March 2006

Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer’s disease

Ricardo F Allegri, Diego Sarasola, Cecilia M Serrano, Fernando E Taragano, Raúl L Arizaga, Judith Butman, Leandro Loñ

Neuropsychiatric Disease and Treatment 2006, 2:105-110

Published Date: 15 March 2006

Introducing residents to geroneuropsychology in one day: an enriched curriculum

Anne Dull Baird, Susanne Wickie, Susan MacNeill, Sara R Friedman, Julia Fitzgerald Smith

Neuropsychiatric Disease and Treatment 2006, 2:101-104

Published Date: 15 March 2006

Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study

Davide Uccellini, G Grampa, I La Spina, D Nasuelli, I Neromante, L Politini, F Reverberi, D Porazzi, V Carli, G Camardese

Neuropsychiatric Disease and Treatment 2006, 2:95-100

Published Date: 15 March 2006

Combination rapid transcranial magnetic stimulation in treatment refractory depression

William M McDonald, Kirk Easley, Eve H Byrd, Paul Holtzheimer, Shannon Tuohy, John L Woodard, Kimberly Beyer, Charles M Epstein

Neuropsychiatric Disease and Treatment 2006, 2:85-94

Published Date: 15 March 2006

Lateralized semantic priming: modulation by levodopa, semantic distance, and participants’ magical beliefs

Christine Mohr, Theodor Landis, Peter Brugger

Neuropsychiatric Disease and Treatment 2006, 2:71-84

Published Date: 15 March 2006

Predator odor exposure facilitates acquisition of a leverpress avoidance response in rats

Francis X Brennan, Kevin D Beck, Richard J Servatius

Neuropsychiatric Disease and Treatment 2006, 2:65-69

Published Date: 15 March 2006

Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications

Regina Rodrigo, Pilar Monfort, Omar Cauli, Slaven Erceg, Vicente Felipo

Neuropsychiatric Disease and Treatment 2006, 2:53-63

Published Date: 15 March 2006

A review of SPECT studies in psychiatry in China

Shenxun Shi, Liang Shu

Neuropsychiatric Disease and Treatment 2006, 2:43-51

Published Date: 15 March 2006

Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications

Peter Gallagher, Allan H Young

Neuropsychiatric Disease and Treatment 2006, 2:33-42

Published Date: 15 March 2006

A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments

Adam B Lewin, Eric A Storch, Gary R Geffken, Wayne K Goodman, Tanya K Murphy

Neuropsychiatric Disease and Treatment 2006, 2:21-31

Published Date: 15 March 2006

Conversion disorder: towards a neurobiological understanding

Samuel B Harvey, Biba R Stanton, Anthony S David

Neuropsychiatric Disease and Treatment 2006, 2:13-20

Published Date: 15 March 2006

Carbamazepine extended-release capsules in bipolar disorder

Richard H Weisler

Neuropsychiatric Disease and Treatment 2006, 2:3-11

Published Date: 15 March 2006

Editorial: The centrifugal tendencies of the stigma attached to mental illness || FREE PAPER ||

Norman Sartorius

Neuropsychiatric Disease and Treatment 2006, 2:1-2

Published Date: 15 March 2006